Insider · CIK 0002077001
Matthew Ross Boyd
Files at ENGN (enGene Holdings Inc.). First filing -, latest -.
In brief
Matthew Ross Boyd files SEC Form 4 as officer at ENGN (enGene Holdings Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Matthew Ross Boyd has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 30, 2026 | ENGN enGene Holdings Inc. | AGrant or award Stock Option (Right to Buy)derivative | +195,000 | $0.00 | $0 | 195,000 | Feb 3, 2026 |
| Jul 8, 2025 | ENGN enGene Holdings Inc. | AGrant or award Stock Option (Right to Buy)derivative | +100,000 | $0.00 | $0 | 100,000 | Jul 14, 2025 |
Questions about Matthew Ross Boyd
Answered from the filings on this page, as of the latest one.
Is Matthew Ross Boyd buying or selling?
Matthew Ross Boyd has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Matthew Ross Boyd's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Matthew Ross Boyd has 0.
Where does Matthew Ross Boyd file Form 4?
Matthew Ross Boyd has filed Form 4 at ENGN (enGene Holdings Inc.) as Chief Regulatory Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.